Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

465 ARTÍCULOS , VIENDO DEL 166 AL 180

Effect of the Tottori familial disease mutation (D7N) on the monomers and dimers of Aβ40 and Aβ42

Viet MH, Nguyen PH, Ngo ST, Li MS, Derreumaux P.

ACS Chem Neurosci. 2013 Nov 20;4(11):1446-57. doi: 10.1021/cn400110d. Epub 2013 Sep 16.

The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study

Cash DM, Ridgway GR, Liang Y, Ryan NS, Kinnunen KM, Yeatman T, Malone IB, Benzinger TL, Jack CR Jr, Thompson PM, Ghetti BF, Saykin AJ, Masters CL, Ringman JM, Salloway SP, Schofield PR, Sperling RA, Cairns NJ, Marcus DS, Xiong C, Bateman RJ, Morris JC, Rossor MN, Ourselin S, Fox NC; Dominantly Inherited Alzheimer Network (DIAN).

Neurology. 2013 Oct 15;81(16):1425-33. doi: 10.1212/WNL.0b013e3182a841c6. Epub 2013 Sep 18.

Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer's disease patients alter calcium homeostasis

Rubio-Moscardo F, Setó-Salvia N, Pera M, Bosch-Morató M, Plata C, Belbin O, Gené G, Dols-Icardo O, Ingelsson M, Helisalmi S, Soininen H, Hiltunen M, Giedraitis V, Lannfelt L, Frank A, Bullido MJ, Combarros O, Sánchez-Juan P, Boada M, Tárraga L, Pastor P, Pérez-Tur J, Baquero M, Molinuevo JL, Sánchez-Valle R, Fuentes-Prior P, Fortea J, Blesa R, Muñoz FJ, Lleó A, Valverde MA, Clarimón J.

PLoS One. 2013 Sep 17;8(9):e74203. doi: 10.1371/journal.pone.0074203. eCollection 2013.

Monophosphoryl lipid A is an lipopolysaccharide-derived Toll-like receptor 4 agonist which may improve Alzheimer's disease pathology

Wang DB.

Expert Opin Biol Ther. 2013 Dec;13(12):1639-41. doi: 10.1517/14712598.2013.838556. Epub 2013 Sep 27.

Epigenetic drugs in Alzheimer's disease

Cuadrado-Tejedor M, Oyarzabal J, Lucas MP, Franco R, García-Osta A.

Biomol Concepts. 2013 Oct;4(5):433-45. doi: 10.1515/bmc-2013-0012.

Estrogen associated gene polymorphisms and their interactions in the progress of Alzheimer's disease

Xing Y, Jia JP, Ji XJ, Tian T.

Prog Neurobiol. 2013 Dec;111:53-74. doi: 10.1016/j.pneurobio.2013.09.006. Epub 2013 Oct 3.

What causes alzheimer's disease?

Armstrong RA.

Folia Neuropathol. 2013;51(3):169-88. doi: 10.5114/fn.2013.37702.

Awake bruxism in a patient with Alzheimer's dementia

Lai MM.

Geriatr Gerontol Int. 2013 Oct;13(4):1076-7. doi: 10.1111/ggi.12086.

Aggravation of Alzheimer's disease symptoms after the earthquake in Japan: A comparative analysis of subcategories

Furukawa K, Ootsuki M, Nitta A, Okinaga S, Kodama M, Arai H.

Geriatr Gerontol Int. 2013 Oct;13(4):1081-2. doi: 10.1111/ggi.12085.

[Epigenetic mechanisms of Alzheimer's disease and related drug research]

Gong HC, Wang YL, Wang HW.

Yao Xue Xue Bao. 2013 Jul;48(7):1005-13.

The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes

Bekkering P, Jafri I, van Overveld FJ, Rijkers GT.

Expert Rev Clin Immunol. 2013 Nov;9(11):1031-41. doi: 10.1586/1744666X.2013.848793. Epub 2013 Oct 21.

Transcriptional regulation and its misregulation in Alzheimer's disease

Chen XF, Zhang YW, Xu H, Bu G.

Mol Brain. 2013 Oct 21;6:44. doi: 10.1186/1756-6606-6-44.

Current concepts in Alzheimer's Disease: molecules, models and translational perspectives

Rutten BP, Steinbusch HW.

Mol Neurodegener. 2013 Oct 22;8:33. doi: 10.1186/1750-1326-8-33.

Blood-brain-barriers in aging and in Alzheimer's disease

Marques F, Sousa JC, Sousa N, Palha JA.

Mol Neurodegener. 2013 Oct 22;8:38. doi: 10.1186/1750-1326-8-38.

Epigenetics of Alzheimer's disease and frontotemporal dementia

Veerappan CS, Sleiman S, Coppola G.

Neurotherapeutics. 2013 Oct;10(4):709-21. doi: 10.1007/s13311-013-0219-0.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias